Skip to Main Content
TRC_PTL_New
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Do Not Crush List
    • First-Time Generics
    • Insulin Safety
    • New Drugs
    • Original Container Meds
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New Podcast Alert: "Meds for Alzheimer Dementia" is now available! Listen for FREE now.
  1. Home
  2. Browse
  3. Cardiology
  4. Resources
  5. Drugs

Drugs

  • Angina (19)
  • Antithrombotics (233)
  • Arrhythmias (118)
  • Blood Pressure (36)
  • Cardiovascular Disease and Depression (6)
  • Cholesterol (90)
  • Dyslipidemia (223)
  • Endocarditis (17)
  • Heart Disease (75)
  • Heart Failure (157)
  • Hypertension (235)
  • Hypotension (15)
  • Ischemic Heart Disease/Acute Coronary Syndromes (280)
  • Myocardial Infarction (43)
  • Peripheral Vascular Disease (5)
  • Pulmonary Arterial Hypertension (2)
  • Raynaud's (2)
  • Resources (686)
    • Charts (92)
    • Drug-Induced Cardiovascular Disease (199)
    • Drug-Induced Stroke (8)
    • Drugs (230)
      • ACE Inhibitors (20)
      • Alpha-Blockers (3)
      • Antiarrhythmics (7)
      • Anticoagulants (105)
      • Antihypertensives (14)
      • Antiplatelets (28)
      • ARBs (19)
      • Beta-Blockers (27)
      • CCBs (15)
      • Diuretics (15)
      • Fibrates (1)
      • Niacin (2)
      • Statins (47)
      • Thrombolytics (6)
    • Guidelines (93)
    • Letters (18)
    • Natural Medicines / Supplements (53)
    • Patient Education (44)
    • PL Voices (193)
    • Quality Measures (47)
  • Stroke (118)
196 - 210 of 230 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Other: Ximelagatran (Exanta) and Liver Toxicity November 2004
Article: patients take BOTH aspirin and Plavix (clopidogrel) October 2004
Other: Concomitant Use of Aspirin and Clopidogrel (Plavix) in Cerebrovascular Disease October 2004
Commentary: An Update on Potential New Uses for Statins July 2004
Article: how to dose Lovenox in patients with renal impairment February 2004
Article: blood clots after long plane flights February 2004
Other: Dosing of Enoxaparin (Lovenox) in Special Patient Populations February 2004
Article: new oral anticoagulant called Exanta (ximelagatran, zye-mel-a-GAT-ran) December 2003
Other: Investigational Drug: Ximelagatran (Exanta) December 2003
Article: Can patients be safely switched from Coumadin to generic warfarin September 2003
Article: conventional doses of warfarin to prevent recurrent venous thromboembolism September 2003
Other: Can Patients be Safely Switched from Brand to Generic Warfarin? September 2003
Other: Low-Intensity versus Conventional-Intensity Warfarin Therapy for Long-Term Prevention of Recurrent Venous Thromboembolism September 2003
Article: aspirin instead of warfarin to prevent stroke in some atrial fibrillation patients June 2003
Other: Utilization of Aspirin for Prevention of Stroke in Atrial Fibrillation June 2003
  • « Prev
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved